Actos Bladder Cancer

ANSWER

Actos side effects have been associated with a hundreds of cases of bladder cancer among diabetes patients prescribed the drug in the United States. In 2011, new warnings were added to the drug’s label that provide additional information about the risks associated with Actos and bladder cancer symptoms users should be on the look out for.

Although many believed that the FDA should have recalled Actos, the medication has been allowed to remain on the market with new warnings approved in August 2011.

The new label now provides additional information about the potential Actos bladder cancer risk when the medication is used for more than a year and advises consumers to immediately notify their doctor if they develop any symptoms of bladder cancer from Actos, which could include:

• Blood in the Urine
• Red Color in the Urine
• new or Worsening Urinary Urgency
• Pain on Urination

ACTOS BLADDER CANCER ATTORNEYS

As a result of Takeda Pharmaceuticals’ failure to adequately research their drug or take steps to ensure consumers and the medical community were aware of the bladder cancer risk, compensation may be available through an Actos lawsuit.

The Actos attorneys at Saiontz & Kirk, P.A. are reviewing potential claims for users diagnosed with bladder cancer after using Actos, ActoPlus Met or Duetact, which all contain the active pharmaceutical ingredient pioglitazone. All of the Actos bladder cancer cases are pursued under a contingency fee arrangement, which means that there are no fees unless a recovery for bladder cancer from Actos is obtained by our attorneys.

REQUEST A CASE EVALUATION

Last Updated September 13, 2011
By Austin Kirk
2 Comments